Literature DB >> 30612180

Chronic use of pentosan polysulfate sodium associated with risk of vision-threatening disease.

Tanner J Ferguson1, Ryan L Geraets2,3, Matthew A Barker2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30612180     DOI： 10.1007/s00192-018-3850-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN： 0937-3462            Impact factor:   2.894


× No keyword cloud information.
  4 in total

1.  Re: FDA BRUDAC 2018 Criteria for Interstitial Cystitis/Bladder Pain Syndrome Clinical Trials: Future Direction for Research: J. C. Nickel and R. Moldwin J Urol 2018;200:39-42.

Authors:  William A Pearce; Adam M Hanif; Nieraj Jain
Journal:  J Urol       Date:  2018-08-03       Impact factor: 7.450

2.  Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis.

Authors:  J Curtis Nickel; Jack Barkin; John Forrest; Phillip G Mosbaugh; J Hernandez-Graulau; David Kaufman; Keith Lloyd; Robert J Evans; C Lowell Parsons; Linda E Atkinson
Journal:  Urology       Date:  2005-04       Impact factor: 2.649

3.  Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium.

Authors:  William A Pearce; Rui Chen; Nieraj Jain
Journal:  Ophthalmology       Date:  2018-05-22       Impact factor: 12.079

4.  Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Ronald B Melles; William F Mieler
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079
  4 in total
  2 in total

1.  Managing Interstitial Cystitis/Bladder Pain Syndrome in Older Adults.

Authors:  Alyssa Gracely; Anne P Cameron
Journal:  Drugs Aging       Date:  2020-10-23       Impact factor: 3.923

Review 2.  The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS?

Authors:  Giuseppe Alessandro Digesu; Visha Tailor; Alka A Bhide; Vik Khullar
Journal:  Int Urogynecol J       Date:  2020-05-01       Impact factor: 2.894
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.